Titlebook: Biological Mechanisms of Minimal Residual Disease and Systemic Cancer; Julio A.‘Aguirre-Ghiso Book 2018 Springer Nature Switzerland AG 201

艦旗

心神不寧

OREX

Friction

https://doi.org/10.1007/978-3-658-18524-4l response exceed 90% and complete response (CR) more than 50% in some studies. Unfortunately, despite higher rates of CR, relapse rates remain high suggesting that persistent disease may not be measured by current techniques. Traditionally, response rates were defined by urine and serum protein ele

Indurate

Biological Mechanisms of Minimal Residual Disease and Systemic Cancer978-3-319-97746-1Series ISSN 0065-2598 Series E-ISSN 2214-8019

APRON

救護車

返老還童

Leisureliness

Advances in Experimental Medicine and Biologyhttp://image.papertrans.cn/b/image/187399.jpg

acolyte

Book 2018ematological malignancies. It reports also on technological advancements for monitoring MRD, derived from mechanistic insights. Chapters in solid and hematological malignancies address stem cell biology, genetics, epigenetics and micro-environmental regulation of dormant MRD. Novel insight into tech